Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · IEX Real-Time Price · USD
1.740
+0.010 (0.58%)
At close: Jul 19, 2024, 4:00 PM
1.760
+0.020 (1.15%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Plus Therapeutics Employees
Plus Therapeutics had 20 employees as of December 31, 2023. The number of employees increased by 3 or 17.65% compared to the previous year.
Employees
20
Change (1Y)
3
Growth (1Y)
17.65%
Revenue / Employee
$304,200
Profits / Employee
-$588,600
Market Cap
9.93M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| PAVmed | 107 |
| Tonix Pharmaceuticals Holding | 103 |
| Pieris Pharmaceuticals | 50 |
| ABVC BioPharma | 19 |
| Moleculin Biotech | 18 |
| Elevai Labs | 18 |
| Inhibikase Therapeutics | 9 |
| Coeptis Therapeutics | 7 |
PSTV News
- 20 days ago - Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer - GlobeNewsWire
- 6 weeks ago - Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT - GlobeNewsWire
- 2 months ago - Plus Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 2 months ago - Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024 - GlobeNewsWire
- 2 months ago - Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial - GlobeNewsWire
- 2 months ago - Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial - GlobeNewsWire
- 2 months ago - Plus Therapeutics Announces Private Placement Financing of up to $18 Million - GlobeNewsWire